| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 497223-25-3 | Cenicriviroc |
≥98% | | 询价 |
| 2 | 388592-44-7 | CK-869 |
≥98% | | 询价 |
| 3 | 1807988-47-1 | IITZ-01 |
≥98% | | 询价 |
| 4 | 936544-53-5 | Palmitoyl Tripeptide-8 |
≥98% | | 询价 |
| 5 | 2227368-54-7 | JH-X-119-01 |
≥98% | | 询价 |
| 6 | 820959-17-9 | Acetyl Tetrapeptide-5 |
≥98% | | 询价 |
| 7 | 928006-88-6 | Acetyl Tetrapeptide-11 |
≥98% | | 询价 |
| 8 | 9003-39-8 | PVP K29/32 |
≥98% | | 询价 |
| 9 | 9003-11-6 | Pluronic F-68 |
≥98% | | 询价 |
| 10 | 175865-59-5 | Valganciclovir HCl |
≥98% | | 询价 |
| 11 | 2249435-90-1 | STING inhibitor 2 |
≥98% | | 询价 |
| 12 | 727699-84-5 | STING inhbitor 1 |
≥98% | | 询价 |
| 13 | 2499663-01-1 | STM2457 |
≥98% | | 询价 |
| 14 | 2036272-55-4 | ALC-0315 |
≥98% | | 询价 |
| 15 | 162408-66-4 | GR 103691 |
≥98% | | 询价 |
| 16 | 1610516-67-0 | ML318 |
≥98% | | 询价 |
| 17 | 2412270-22-3 | CA77,1 |
≥98% | | 询价 |
| 18 | 6054-98-4 | Olsalazine Sodium(CJ-91B) |
≥98% | | 询价 |
| 19 | 474432-65-0 | FAUC-346 |
≥98% | | 询价 |
| 20 | 51070-56-5 | JFD01307SC |
≥98% | | 询价 |
| 21 | 2226664-93-1 | KY19382 |
≥98% | | 询价 |
| 22 | 199864-88-5 | RS-127445 maleate |
≥98% | | 询价 |
| 23 | 1803605-68-6 | ICCB-19 HCl |
≥98% | | 询价 |
| 24 | 2375595-72-3 | MEISi-2 |
≥98% | | 询价 |
| 25 | 1256094-31-1 | AI-10-47 |
≥98% | | 询价 |
| 26 | 939228-52-1 | CCI 007 |
≥98% | | 询价 |
| 27 | 1480724-61-5 | Vosoritide(BMN-111 Voxzogo) |
≥98% | | 询价 |
| 28 | 1628423-76-6 | Pafolacianine(OTL-0038 OTL-38 Cytalux) |
≥98% | | 询价 |
| 29 | 9002-64-6 | Recombinant human parathyroid hormone(Preotact Natpara) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | | SLEC-11 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | | AL-GDa62 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | | IHCH-3064 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 2170834-63-4 | Xeruborbactam(QPX7728) |
≥98% | | 询价 |
| 34 | | QPX7831 |
≥98% | | 询价 |
| 35 | | MK-4688 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | | WS-898 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | | DNDI-6148 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | | BAY-091 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | | BAY-297 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | | OXS-007417 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 2170126-74-4 | BMS-986278 |
≥98% | | 询价 |
| 42 | | SY-5609 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | | UBTR008295a |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | | IHMT-EZH2-115 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | | HLB-0532247 |
≥98% | | 询价 |
| 46 | 2364554-48-1 | Aficamten(CK-3773274 CK-274) |
≥98% | | 询价 |
| 47 | 302962-49-8 | Dasatinib(BMS354825 Sprycel) |
≥98% | | 询价 |
| 48 | 136661-76-2 | Defensin HNP-3(human) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | 120721-97-3 | Defensin HNP-2(human) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | 136661-76-2 | Defensin HNP-1(human) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | | α-Defensin 6 |
≥98% | | 询价 |
| 52 | | H-Ser-Ser-Arg-Leu-Ala-EDANS |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | | DABCYL-Arg-Gly-Val-Val-Asn-Ala-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 54 | 163265-38-1 | Fluorogenic Human CMV Protease Substrate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | | Human CMV Assemblin Protease Substrate(M-site) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | | Human CMV Assemblin Protease Inhibitor |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 204909-38-6 | Ac-tBu-Gly-tBu-Gly-Asn(Me)2-Ala-AMC |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 142878-79-3 | (Tyr0)-C-Type Natriuretic Peptide(32-53)(human,porcine,rat) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | | Cortistatin-29(human)trifluoroacetate salt |
≥98% | | 询价 |
| 60 | 1815618-17-7 | Cortistatin-29(rat) |
≥98% | | 询价 |
m.cnreagent.com